Andrea Mohr
Colchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression.
Journal: Cytotherapy
Published: January 11, 2026
Fas-threshold signalling in MSCs promotes pancreatic cancer progression and metastasis.
Journal: Cancer letters
Published: March 04, 2021
MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells.
Journal: Cancers
Published: March 04, 2019
The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts.
Journal: Cancer letters
Published: October 02, 2017
Caspase-10: a molecular switch from cell-autonomous apoptosis to communal cell death in response to chemotherapeutic drug treatment.
Journal: Cell death and differentiation
Published: February 06, 2017
DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Journal: Cancer biology & therapy
Published: December 09, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026